A share price of Reviva Pharmaceuticals Holdings Inc [RVPH] is currently trading at $1.94, down -3.00%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RVPH shares have gain 22.78% over the last week, with a monthly amount glided 35.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] stock has seen the most recent analyst activity on September 20, 2023, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $12. Previously, The Benchmark Company started tracking the stock with Speculative Buy rating on June 08, 2023, and set its price target to $17. On January 24, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $10 on the stock.
Reviva Pharmaceuticals Holdings Inc experienced fluctuations in its stock price throughout the past year between $0.60 and $4.83. Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] shares were valued at $1.94 at the most recent close of the market.
Analyzing the RVPH fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -4.38, Equity is 11.46 and Total Capital is 3.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.83 points at the first support level, and at 1.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.05, and for the 2nd resistance point, it is at 2.15.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Reviva Pharmaceuticals Holdings Inc [NASDAQ:RVPH] is 0.39. In addition, the Quick Ratio stands at 0.39 and the Cash Ratio stands at 0.32.
